Pub Date : 2022-01-01DOI: 10.4149/cardiol_2022_3_2
P. Mitro
{"title":"Kardiostimulácia v terapii vazovagálnej synkopy – nové technológie a staré otázniky / Cardiac pacing in the treatment of vasovagal syncope – new technologies and old questions","authors":"P. Mitro","doi":"10.4149/cardiol_2022_3_2","DOIUrl":"https://doi.org/10.4149/cardiol_2022_3_2","url":null,"abstract":"","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70878343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.4149/cardiol_2022_3_3
M. Huňavý, C. Gibarti, R. Koribský, J. Gonsorcík
{"title":"Význam CT koronarografie v diagnostike a manažmente koronárnej choroby srdca / Significance of CT coronary angiography in diagnosis and management of coronary artery disease","authors":"M. Huňavý, C. Gibarti, R. Koribský, J. Gonsorcík","doi":"10.4149/cardiol_2022_3_3","DOIUrl":"https://doi.org/10.4149/cardiol_2022_3_3","url":null,"abstract":"","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70878521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.4149/cardiol_2022_3_1
G. Kaliská, P. Margitfalvi, J. Kmec
{"title":"Komentár k Odporúčaniam Európskej kardiologickej spoločnosti (2021) o kardiostimulácii a srdcovej resynchronizačnej liečbe / Comment on 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","authors":"G. Kaliská, P. Margitfalvi, J. Kmec","doi":"10.4149/cardiol_2022_3_1","DOIUrl":"https://doi.org/10.4149/cardiol_2022_3_1","url":null,"abstract":"","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70878131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.4149/CARDIOL_2020_5_6_6
S. Mišíková, S. Juhás, D. Ondusova, M. Šimurda
Objective: The aim of the observational, retrospective and single-centre study is to analyse early and late complications due to left atrial appendage occlusion with Amplatzer AmuletTM. Methods: We analyzed 49 patients (21 female and 28 male) with mean age of 72.1 ± 7.4 years. All patients were diagnosed with non-valvular atrial fibrillation and with high risk of thromboembolic (CHA2DS2-VASc 4,1 ± 1.3) and bleeding (HASBLED 3.3 ± 0.9) complications. We observed periprocedure, early (within 7 days after the procedure) and late complications: vascular, bleeding, stroke, systemic embolization, device embolization, pericardiac effusion and death. Results: The left atrial appendage was successfully managed in 47 (94.9%) patients. We observed one periprocedural complication – thrombus on the sheath. During follow-up 18.2 ± 17.7 month we observed one intracranial bleeding, one chronic pericardial effusion and 8 deaths. There was no connection between procedure and death in 5 patients, in 3 patients we were unable to determine the cause of death. Conclusion: Left atrial appendage occlusion is an effective and safe alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation and contraindication of anticoagulation therapy. The risk of complication is low thanks to correct selection of patients, strict compliance with the deployment rules and careful monitoring of patients. Fig. 3, Tab. 6. Ref. 39, on-line full text (Free, PDF) www.cardi-
{"title":"Katetrizačný uzáver uška ľavej predsiene, včasné a neskoré komplikácie / Left atrial appendage occlusion, early and late complications","authors":"S. Mišíková, S. Juhás, D. Ondusova, M. Šimurda","doi":"10.4149/CARDIOL_2020_5_6_6","DOIUrl":"https://doi.org/10.4149/CARDIOL_2020_5_6_6","url":null,"abstract":"Objective: The aim of the observational, retrospective and single-centre study is to analyse early and late complications due to left atrial appendage occlusion with Amplatzer AmuletTM. Methods: We analyzed 49 patients (21 female and 28 male) with mean age of 72.1 ± 7.4 years. All patients were diagnosed with non-valvular atrial fibrillation and with high risk of thromboembolic (CHA2DS2-VASc 4,1 ± 1.3) and bleeding (HASBLED 3.3 ± 0.9) complications. We observed periprocedure, early (within 7 days after the procedure) and late complications: vascular, bleeding, stroke, systemic embolization, device embolization, pericardiac effusion and death. Results: The left atrial appendage was successfully managed in 47 (94.9%) patients. We observed one periprocedural complication – thrombus on the sheath. During follow-up 18.2 ± 17.7 month we observed one intracranial bleeding, one chronic pericardial effusion and 8 deaths. There was no connection between procedure and death in 5 patients, in 3 patients we were unable to determine the cause of death. Conclusion: Left atrial appendage occlusion is an effective and safe alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation and contraindication of anticoagulation therapy. The risk of complication is low thanks to correct selection of patients, strict compliance with the deployment rules and careful monitoring of patients. Fig. 3, Tab. 6. Ref. 39, on-line full text (Free, PDF) www.cardi-","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70877849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The use of deformation parameters in assessment of left ventricle subclinical dysfunction. Cardiology Lett. 2021;30(1):31–36 Abstract. Normal ejection fraction does not truly mean normal systolic function of the myocardium. The ejection mechanism is a complex motion consisting of many shears and rotation. The deformation in longitudinal direction is the most vulnerable part of this complex move. The initial impairment of longitudinal strain is not truly visible by simple, eyeballing, in the echocardiographic examination. The speckle tracking method is an appropriate method to detect such small impairments. In the last 15 years this method has became standard, the reference values have been set up and finally it has found clinical applications. It seems to be useful in cases in which it is necessary to evaluate if the systolic function is already subclinically damaged: typically in severe asymptomatic aortic stenosis, in cardiooncology or in differential diagnosis of thick wall myocardium. The speckle tracking option will soon be a standard part of the software package of every ultrasound machine so it is good to emphasize some practical aspects of dataset aquisition. Tab. 1, Fig. 5, Ref. 42, on-line full text (Free, PDF) www.cardiologyletters.sk
{"title":"Hodnotenie subklinickej systolickej dysfunkcie ľavej komory pomocou parametrov deformácie / The use of deformation parameters in assessment of left ventricle subclinical dysfunction","authors":"Hodnotenie subklinickej, systolickej dysfunkcie ľavej, komory pomocou, parametrov deformácie","doi":"10.4149/CARDIOL_2021_1_6","DOIUrl":"https://doi.org/10.4149/CARDIOL_2021_1_6","url":null,"abstract":"The use of deformation parameters in assessment of left ventricle subclinical dysfunction. Cardiology Lett. 2021;30(1):31–36 Abstract. Normal ejection fraction does not truly mean normal systolic function of the myocardium. The ejection mechanism is a complex motion consisting of many shears and rotation. The deformation in longitudinal direction is the most vulnerable part of this complex move. The initial impairment of longitudinal strain is not truly visible by simple, eyeballing, in the echocardiographic examination. The speckle tracking method is an appropriate method to detect such small impairments. In the last 15 years this method has became standard, the reference values have been set up and finally it has found clinical applications. It seems to be useful in cases in which it is necessary to evaluate if the systolic function is already subclinically damaged: typically in severe asymptomatic aortic stenosis, in cardiooncology or in differential diagnosis of thick wall myocardium. The speckle tracking option will soon be a standard part of the software package of every ultrasound machine so it is good to emphasize some practical aspects of dataset aquisition. Tab. 1, Fig. 5, Ref. 42, on-line full text (Free, PDF) www.cardiologyletters.sk","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70878272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.4149/CARDIOL_2021_1_2
M. Dúbrava
Na konci roka 2019 sme sa s úsmevom divili, ako rýchlo Číňania stavajú nemocnicu pre akúsi ich pandémiu (1). Vyvolávajúci „nový vírus “ SARS-CoV-2 „nového ochorenia“, akronymicky nazývaného COVID-19 (z COrona VIrus Disease 2019), bol identifikovaný 3. januára 2020 (2). V Európe bol prvý pacient zrejme diagnostikovaný 20. februára 2020 v Taliansku (3). Na Slovensku sa nestačíme diviť od jari 2020: prvý COVID-19 pacient (A. Č.) bol u nás hospitalizovaný 5. marca 2020 na Klinike infektológie a geografickej medicíny UNB, LFUK a SZU Bratislava. Diviť sme sa zjavne neprestali doteraz, inak by sme si „rok po“ nemuseli nástojčivo klásť otázku, prečo na Slovensku zomiera pre COVID (pre zjednodušenie budeme abstrahovať od do istej miery sekundárnej diskusie, či na COVID alebo s COVID-om) násobne viac ľudí, ako v absolútnej väčšine vyspelých krajín (4). Pritom musíme mať na pamäti, že dramatický vzostup COVID mortality nastal na Slovensku extrémne rýchlo – „v priebehu mesiaca“.
{"title":"Prečo dnes na Slovensku excesívne zomierame pre SARS-CoV-2?","authors":"M. Dúbrava","doi":"10.4149/CARDIOL_2021_1_2","DOIUrl":"https://doi.org/10.4149/CARDIOL_2021_1_2","url":null,"abstract":"Na konci roka 2019 sme sa s úsmevom divili, ako rýchlo Číňania stavajú nemocnicu pre akúsi ich pandémiu (1). Vyvolávajúci „nový vírus “ SARS-CoV-2 „nového ochorenia“, akronymicky nazývaného COVID-19 (z COrona VIrus Disease 2019), bol identifikovaný 3. januára 2020 (2). V Európe bol prvý pacient zrejme diagnostikovaný 20. februára 2020 v Taliansku (3). Na Slovensku sa nestačíme diviť od jari 2020: prvý COVID-19 pacient (A. Č.) bol u nás hospitalizovaný 5. marca 2020 na Klinike infektológie a geografickej medicíny UNB, LFUK a SZU Bratislava. Diviť sme sa zjavne neprestali doteraz, inak by sme si „rok po“ nemuseli nástojčivo klásť otázku, prečo na Slovensku zomiera pre COVID (pre zjednodušenie budeme abstrahovať od do istej miery sekundárnej diskusie, či na COVID alebo s COVID-om) násobne viac ľudí, ako v absolútnej väčšine vyspelých krajín (4). Pritom musíme mať na pamäti, že dramatický vzostup COVID mortality nastal na Slovensku extrémne rýchlo – „v priebehu mesiaca“.","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70877936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.4149/CARDIOL_2021_1_5
M. Mariani, G. Mattioli, M. Condorelli, A. Dagianti, O. Biadi, G. Geraci, M. Chiariello, F. Fedele
{"title":"STUDIO POLICENTRICO NELL'ANGINA DA SFORZO CON DILTIAZEM VERSO PROPRANOLOLO","authors":"M. Mariani, G. Mattioli, M. Condorelli, A. Dagianti, O. Biadi, G. Geraci, M. Chiariello, F. Fedele","doi":"10.4149/CARDIOL_2021_1_5","DOIUrl":"https://doi.org/10.4149/CARDIOL_2021_1_5","url":null,"abstract":"","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"30 1","pages":"23-29"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70878209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.4149/CARDIOL_2021_1_1
P. Hlivák, R. Hatala
{"title":"Komentár k Odporúčaniam ESC pre manažment pacientov \u0000so supraventrikulárnymi tachykardiami z roku 2019","authors":"P. Hlivák, R. Hatala","doi":"10.4149/CARDIOL_2021_1_1","DOIUrl":"https://doi.org/10.4149/CARDIOL_2021_1_1","url":null,"abstract":"","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70877858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：